Dr. Yasemin van Heuvel

Pharmaceutical Biotechnology: Research in the area of retroviral vectors and production cell lines for biologics.

Coordinating marketing-, medical-, brand- and other projects in a project leader role, and coordinating with cross-functional and international teams. Creation of content for multiple channels (print and digital) and applications, conducting interviews and research as needed. Event coordination and product launch support in the area of Pharmacogenetics.

Translational research in the area of pharmaceutical biotechnology. Fields of activity: Cloning and protein purification of vaccine candidates.

Clinical genetic dopamine studies: Recruitment of test persons, execution and evaluation of neuropsychological tests, supervision and set up of PET Scans, variable tests of health and physical fitness of the test persons.

GLP, GMP, GCP, Pharmacovigilance

Grundkurs gem. § 28 Abs. 2, Satz 1 Nr. 3 GenTSV

Drug research on a novel peptide-based antibiotic. ETH-Zuerich, Institute of microbiology. Aebi Lab. 2 Publications: https://www.nature.com/articles/s41396-018-0293-8 https://pubs.acs.org/doi/abs/10.1021/acs.biochem.7b00697

Specification: Neuroscience.

Specification: Neuroscience. Bachelor Thesis in Neuroanatomy (MS-Study): Oligodendrocyte stress in the cuprizone model is characterized by a selective expression of the transcription factors CHOP and ATF3. 2 Publications: https://www.ncbi.nlm.nih.gov/pubmed/?term=yasemin+van+heuvel